The U.S. Food and Drug Administration approved a new drug from Bristol-Myers Squibb Co. to treat patients with metastatic or late-stage melanoma, the most deadly type of skin cancer.
WSJ.com: What's News US, Wall Street Journal: Home US
Fri, 03/25/2011 - 10:42am
The U.S. Food and Drug Administration approved a new drug from Bristol-Myers Squibb Co. to treat patients with metastatic or late-stage melanoma, the most deadly type of skin cancer.